Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition.

Plusquin C, Fastrez M, Vandromme J, Rozenberg S.

Maturitas. 2012 Oct;73(2):164-6. doi: 10.1016/j.maturitas.2012.06.014. Epub 2012 Sep 7.

PMID:
22964073
2.

Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey.

Plusquin C, Fastrez M, Vandromme J, Rozenberg S.

Maturitas. 2011 Dec;70(4):391-4. doi: 10.1016/j.maturitas.2011.09.007. Epub 2011 Oct 19.

PMID:
22014472
3.

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.

Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH.

Obstet Gynecol. 2006 Sep;108(3 Pt 1):515-20.

PMID:
16946209
4.

Role of prophylactic hysterectomy in patients at high risk for hereditary cancers.

Villella JA, Parmar M, Donohue K, Fahey C, Piver MS, Rodabaugh K.

Gynecol Oncol. 2006 Sep;102(3):475-9. Epub 2006 Feb 13.

PMID:
16473397
5.

Elective oophorectomy in the United States: trends and in-hospital complications, 1998-2006.

Asante A, Whiteman MK, Kulkarni A, Cox S, Marchbanks PA, Jamieson DJ.

Obstet Gynecol. 2010 Nov;116(5):1088-95. doi: 10.1097/AOG.0b013e3181f5ec9d.

PMID:
20966693
6.

The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice?

Brand AH.

Aust N Z J Obstet Gynaecol. 2011 Aug;51(4):296-300. doi: 10.1111/j.1479-828X.2011.01308.x. Epub 2011 Mar 29.

PMID:
21806570
7.

Oophorectomy in premenopausal women: health-related quality of life and sexual functioning.

Teplin V, Vittinghoff E, Lin F, Learman LA, Richter HE, Kuppermann M.

Obstet Gynecol. 2007 Feb;109(2 Pt 1):347-54.

PMID:
17267835
8.

Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.

Berek JS, Chalas E, Edelson M, Moore DH, Burke WM, Cliby WA, Berchuck A; Society of Gynecologic Oncologists Clinical Practice Committee..

Obstet Gynecol. 2010 Sep;116(3):733-43. doi: 10.1097/AOG.0b013e3181ec5fc1. Review.

PMID:
20733460
10.

Factors affecting prophylactic oophorectomy in postmenopausal women.

Gross CP, Nicholson W, Powe NR.

Obstet Gynecol. 1999 Dec;94(6):962-8.

PMID:
10576183
11.

Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions.

Töz E, Özcan A, Balsak D, Avc ME, Eraslan AG, Balc DD.

Menopause. 2016 Feb;23(2):138-42. doi: 10.1097/GME.0000000000000511.

PMID:
26382316
12.
13.

Bilateral oophorectomy and the risk of incident diabetes in postmenopausal women.

Appiah D, Winters SJ, Hornung CA.

Diabetes Care. 2014;37(3):725-33. doi: 10.2337/dc13-1986. Epub 2013 Nov 5.

PMID:
24194507
14.

Is incidental prophylactic oophorectomy an acceptable means to reduce the incidence of ovarian cancer?

Rozario D, Brown I, Fung MF, Temple L.

Am J Surg. 1997 Jun;173(6):495-8.

PMID:
9207161
15.

Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy.

Aziz A, Bergquist C, Brännström M, Nordholm L, Silfverstolpe G.

Acta Obstet Gynecol Scand. 2005 Sep;84(9):854-9.

PMID:
16097975
16.

Ovarian conservation at the time of hysterectomy for benign disease.

Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS.

Obstet Gynecol. 2005 Aug;106(2):219-26.

PMID:
16055568
17.

Trends in bilateral oophorectomy at the time of hysterectomy for benign disease.

Novetsky AP, Boyd LR, Curtin JP.

Obstet Gynecol. 2011 Dec;118(6):1280-6. doi: 10.1097/AOG.0b013e318236fe61.

PMID:
22105256
18.

Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.

Evans EC, Matteson KA, Orejuela FJ, Alperin M, Balk EM, El-Nashar S, Gleason JL, Grimes C, Jeppson P, Mathews C, Wheeler TL, Murphy M; Society of Gynecologic Surgeons Systematic Review Group..

Obstet Gynecol. 2016 Sep;128(3):476-85. doi: 10.1097/AOG.0000000000001592. Review.

PMID:
27500347
19.

[Profits of post-menopausal ovarian conservation at the time of hysterectomy for benign disease: mirage or reality?].

Ouldamer L, Marret H, Jacquet A, Denakpo J, Body G.

J Gynecol Obstet Biol Reprod (Paris). 2013 Apr;42(2):123-9. doi: 10.1016/j.jgyn.2012.10.014. Epub 2012 Nov 30. Review. French.

20.

Ovarian conservation at the time of hysterectomy for benign disease.

Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS.

Clin Obstet Gynecol. 2007 Jun;50(2):354-61. Review.

PMID:
17513923

Supplemental Content

Support Center